FGHQF
Price
$0.15
Change
+$0.05 (+50.00%)
Updated
Jul 31 closing price
Capitalization
372.86M
ZVRA
Price
$9.36
Change
-$0.09 (-0.95%)
Updated
Aug 25, 04:59 PM (EDT)
Capitalization
525.42M
72 days until earnings call
Interact to see
Advertisement

FGHQF vs ZVRA

Header iconFGHQF vs ZVRA Comparison
Open Charts FGHQF vs ZVRABanner chart's image
Frontage
Price$0.15
Change+$0.05 (+50.00%)
Volume$130
Capitalization372.86M
Zevra Therapeutics
Price$9.36
Change-$0.09 (-0.95%)
Volume$17.69K
Capitalization525.42M
FGHQF vs ZVRA Comparison Chart in %
Loading...
FGHQF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZVRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FGHQF vs. ZVRA commentary
Aug 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FGHQF is a Buy and ZVRA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 26, 2025
Stock price -- (FGHQF: $0.15 vs. ZVRA: $9.44)
Brand notoriety: FGHQF and ZVRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FGHQF: 0% vs. ZVRA: 87%
Market capitalization -- FGHQF: $372.86M vs. ZVRA: $525.42M
FGHQF [@Biotechnology] is valued at $372.86M. ZVRA’s [@Biotechnology] market capitalization is $525.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $99.72B to $0. The average market capitalization across the [@Biotechnology] industry is $1.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FGHQF’s FA Score shows that 1 FA rating(s) are green whileZVRA’s FA Score has 1 green FA rating(s).

  • FGHQF’s FA Score: 1 green, 4 red.
  • ZVRA’s FA Score: 1 green, 4 red.
According to our system of comparison, FGHQF is a better buy in the long-term than ZVRA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FGHQF’s TA Score shows that 0 TA indicator(s) are bullish while ZVRA’s TA Score has 4 bullish TA indicator(s).

  • FGHQF’s TA Score: 0 bullish, 1 bearish.
  • ZVRA’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, FGHQF is a better buy in the short-term than ZVRA.

Price Growth

FGHQF (@Biotechnology) experienced а 0.00% price change this week, while ZVRA (@Biotechnology) price change was +0.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.14%. For the same industry, the average monthly price growth was +18.77%, and the average quarterly price growth was +29.32%.

Reported Earning Dates

ZVRA is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+2.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZVRA($525M) has a higher market cap than FGHQF($373M). FGHQF YTD gains are higher at: 48.317 vs. ZVRA (13.189).
FGHQFZVRAFGHQF / ZVRA
Capitalization373M525M71%
EBITDAN/A36.4M-
Gain YTD48.31713.189366%
P/E Ratio374.50N/A-
RevenueN/A62M-
Total CashN/A203M-
Total DebtN/A62.3M-
FUNDAMENTALS RATINGS
ZVRA: Fundamental Ratings
ZVRA
OUTLOOK RATING
1..100
73
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
PROFIT vs RISK RATING
1..100
76
SMR RATING
1..100
87
PRICE GROWTH RATING
1..100
56
P/E GROWTH RATING
1..100
25
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FGHQFZVRA
RSI
ODDS (%)
N/A
Bullish Trend 4 days ago
78%
Stochastic
ODDS (%)
N/A
Bullish Trend 4 days ago
81%
Momentum
ODDS (%)
N/A
Bearish Trend 4 days ago
83%
MACD
ODDS (%)
Bearish Trend 4 days ago
20%
Bearish Trend 5 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
3%
Bullish Trend 4 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
4%
Bearish Trend 4 days ago
77%
Advances
ODDS (%)
N/A
Bullish Trend 5 days ago
81%
Declines
ODDS (%)
N/A
Bearish Trend 12 days ago
77%
BollingerBands
ODDS (%)
N/A
Bullish Trend 4 days ago
83%
Aroon
ODDS (%)
N/A
Bearish Trend 4 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
FGHQF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZVRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HUMEX16.830.50
+3.06%
Huber Mid Cap Value Instl
MUSBX36.770.55
+1.52%
MFS Blended Research Core Equity B
PRERX27.890.39
+1.42%
Principal Real Estate Securities R3
PPYIX9.350.13
+1.41%
PIMCO RAE International Instl
WFEAX15.230.21
+1.40%
Allspring International Equity A

FGHQF and

Correlation & Price change

A.I.dvisor tells us that FGHQF and ANL have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FGHQF and ANL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FGHQF
1D Price
Change %
FGHQF100%
N/A
ANL - FGHQF
25%
Poorly correlated
-0.86%
SKYE - FGHQF
15%
Poorly correlated
-7.32%
LEXX - FGHQF
9%
Poorly correlated
+0.88%
HMTXF - FGHQF
8%
Poorly correlated
+3.36%
ZVRA - FGHQF
4%
Poorly correlated
-0.74%
More

ZVRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZVRA has been loosely correlated with ACLX. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if ZVRA jumps, then ACLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZVRA
1D Price
Change %
ZVRA100%
-0.74%
ACLX - ZVRA
34%
Loosely correlated
-0.68%
ATXS - ZVRA
34%
Loosely correlated
+6.93%
IMTX - ZVRA
34%
Loosely correlated
+1.07%
AXON - ZVRA
33%
Loosely correlated
+0.36%
COGT - ZVRA
33%
Loosely correlated
+2.97%
More